Kodiak Sciences
KOD
97.17
-0.73
-0.75%
Kodiak Sciences
US · KOD
#1934 by market cap
Listed 2018
97.17
-0.73
-0.75%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:57
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
- Total institutional ownership rose 2.9 percentage points.
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 105.52% +2.89pp
- Institutions
- 241 +1
- As of
- 2026/Q3 vs. prior period
Holder types
Hedge Fund52.19%
Mutual Fund43.88%
Individual/Insider6.29%
Public Company4.57%
VC/PE Fund2.33%
Endowment Fund1.10%
Private Company0.52%
Government Pension Fund0.39%
Insurance Company0.33%
Family Office/Trust0.20%
Top holders as of 2026-11-05
Baker Bros. Advisors LP
35.25% · 22.11M sh
T. Rowe Price Group, Inc.
7.53% · 4.73M sh
BlackRock
6.08% · 3.81M sh
Victor Perlroth
5.86% · 3.68M sh
Sirenia Capital Management LP
5.57% · 3.50M sh
State Street Global Advisors
3.55% · 2.23M sh
The Goldman Sachs Group, Inc.
3.06% · 1.92M sh
Braidwell LP
2.85% · 1.79M sh
Vanguard Capital Management, LLC
2.83% · 1.78M sh
Janus Henderson Group plc
2.43% · 1.53M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
40 filings tracked · 33 buys · 7 sells
| Name | Role | Stake |
|---|---|---|
| Baker Bros. Advisors LP | -- | 35.25% |
| Victor Perlroth | Chairperson & CEO | 5.86% |
| John Borgeson | Chief Financial Officer | 0.34% |
| Charles Bancroft | Independent Director | 0.04% |
| Taiyin Yang | Independent Director | 0.03% |
| Robert Profusek | Lead Independent Director | 0.02% |
| Richard Levy | Independent Director | 0.00% |
| Bassil Dahiyat | Independent Director | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-04 | Baker Bros. Advisors LP | -- | Open Market Acquisition | +247,090 | $98.51 |
| 2026-10-22 | Taiyin Yang | Independent Director | Derivative Exercise and Retained | +20,000 | $2.35 |
| 2026-10-20 | John Borgeson | Chief Financial Officer | Derivative Exercise and Sale | -30,000 | $2.49–94.91 |
| 2026-09-24 | Victor Perlroth | Chairperson & CEO | Derivative Exercise and Retained | +1,280,524 | $2.49–5.38 |
| 2026-07-14 | John Borgeson | Chief Financial Officer | Other Derivative Acquisition | +66,500 | $42.42 |
| 2026-07-14 | Victor Perlroth | Chairperson & CEO | Other Derivative Acquisition | +100,000 | $42.42 |
| 2026-06-29 | Robert Profusek | Lead Independent Director | Other Derivative Acquisition | +17,731 | $38.96 |
| 2026-06-29 | Richard Levy | Independent Director | Other Derivative Acquisition | +17,731 | $38.96 |
| 2026-06-29 | Bassil Dahiyat | Independent Director | Other Derivative Acquisition | +17,731 | $38.96 |
| 2026-06-29 | Taiyin Yang | Independent Director | Other Derivative Acquisition | +17,731 | $38.96 |
| 2026-06-29 | Baker Bros. Advisors LP | -- | Other Derivative Acquisition | +35,462 | $38.96 |
| 2026-06-29 | Charles Bancroft | Independent Director | Other Derivative Acquisition | +17,731 | $38.96 |
| 2026-06-03 | John Borgeson | Chief Financial Officer | Derivative Exercise and Sale | -30,000 | $1.04–34.67 |
| 2026-04-14 | John Borgeson | Chief Financial Officer | Derivative Exercise and Retained | +28,614 | $1.04 |
| 2026-04-01 | John Borgeson | Chief Financial Officer | Derivative Exercise and Sale | -30,000 | $1.04–41.77 |
| 2026-03-24 | Victor Perlroth | Chairperson & CEO | Derivative Exercise and Retained | +300,000 | $1.04 |
| 2026-03-17 | Victor Perlroth | Chairperson & CEO | Other Derivative Acquisition | +175,000 | $25.00 |
| 2025-12-25 | Victor Perlroth | Chairperson & CEO | Other Disposition | -12,500 | -- |
| 2025-07-03 | John Borgeson | Chief Financial Officer | Other Derivative Acquisition | +250,000 | $3.95 |
| 2025-07-03 | Victor Perlroth | Chairperson & CEO | Other Derivative Acquisition | +340,000 | $3.95 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:57:11 · For reference only, not investment advice and not tailored to your situation.
Kodiak Sciences discussion 0 comments